Computer-Aided Drug Design Methods.

VMD: visual molecular dynamics. J Mol Graph (1996) 117.02

The Protein Data Bank: a computer-based archival file for macromolecular structures. J Mol Biol (1977) 90.57

Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol (1993) 64.61

Scalable molecular dynamics with NAMD. J Comput Chem (2005) 59.49

All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B (1998) 54.00

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev (2001) 36.00

The Amber biomolecular simulation programs. J Comput Chem (2005) 28.84

CHARMM: the biomolecular simulation program. J Comput Chem (2009) 27.71

GROMACS: fast, flexible, and free. J Comput Chem (2005) 27.22

AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem (2010) 25.20

Development and testing of a general amber force field. J Comput Chem (2004) 23.29

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem (2009) 23.19

Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation. J Mol Biol (1999) 15.00

Open Babel: An open chemical toolbox. J Cheminform (2011) 11.12

SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res (2014) 8.86

CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem (2010) 8.79

Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov (2004) 8.10

Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model (2006) 7.93

ZINC: a free tool to discover chemistry for biology. J Chem Inf Model (2012) 6.57

New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem (2010) 6.54

CHARMM-GUI: a web-based graphical user interface for CHARMM. J Comput Chem (2008) 5.81

Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles. J Chem Theory Comput (2012) 5.57

DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J Comput Aided Mol Des (2001) 4.54

Where will new antibiotics come from? Nat Rev Microbiol (2003) 3.99

Statistically optimal analysis of samples from multiple equilibrium states. J Chem Phys (2008) 3.87

Changing patterns of infectious disease. Nature (2000) 3.21

A threading-based method (FINDSITE) for ligand-binding site prediction and functional annotation. Proc Natl Acad Sci U S A (2007) 3.15

Efficient drug lead discovery and optimization. Acc Chem Res (2009) 2.90

Reoptimization of MDL keys for use in drug discovery. J Chem Inf Comput Sci (2002) 2.86

Predicting protein ligand binding sites by combining evolutionary sequence conservation and 3D structure. PLoS Comput Biol (2009) 2.82

Constant pH molecular dynamics with proton tautomerism. Biophys J (2005) 2.44

Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges. J Chem Inf Model (2012) 2.20

Automation of the CHARMM General Force Field (CGenFF) I: bond perception and atom typing. J Chem Inf Model (2012) 2.17

Why do we need so many chemical similarity search methods? Drug Discov Today (2002) 2.12

Statistical clustering techniques for the analysis of long molecular dynamics trajectories: analysis of 2.2-ns trajectories of YPGDV. Biochemistry (1993) 2.12

OpenMM 4: A Reusable, Extensible, Hardware Independent Library for High Performance Molecular Simulation. J Chem Theory Comput (2012) 2.07

Computer-based de novo design of drug-like molecules. Nat Rev Drug Discov (2005) 1.83

Computation of binding free energy with molecular dynamics and grand canonical Monte Carlo simulations. J Chem Phys (2008) 1.66

Computational fragment-based binding site identification by ligand competitive saturation. PLoS Comput Biol (2009) 1.61

Computational methods in drug discovery. Pharmacol Rev (2013) 1.51

How does consensus scoring work for virtual library screening? An idealized computer experiment. J Chem Inf Comput Sci (2001) 1.45

Consideration of molecular weight during compound selection in virtual target-based database screening. J Chem Inf Comput Sci (2003) 1.37

2D conformationally sampled pharmacophore: a ligand-based pharmacophore to differentiate delta opioid agonists from antagonists. J Am Chem Soc (2003) 1.36

Reproducing crystal binding modes of ligand functional groups using Site-Identification by Ligand Competitive Saturation (SILCS) simulations. J Chem Inf Model (2011) 1.26

Pharmer: efficient and exact pharmacophore search. J Chem Inf Model (2011) 1.22

Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity. J Med Chem (2007) 1.22

Extension of the CHARMM General Force Field to sulfonyl-containing compounds and its utility in biomolecular simulations. J Comput Chem (2012) 1.20

Similarity coefficients for binary chemoinformatics data: overview and extended comparison using simulated and real data sets. J Chem Inf Model (2012) 1.19

Computational identification of inhibitors of protein-protein interactions. Curr Top Med Chem (2007) 1.14

Identification and validation of human DNA ligase inhibitors using computer-aided drug design. J Med Chem (2008) 1.10

Discovery of a new class of non-β-lactam inhibitors of penicillin-binding proteins with Gram-positive antibacterial activity. J Am Chem Soc (2014) 1.10

Inclusion of multiple fragment types in the site identification by ligand competitive saturation (SILCS) approach. J Chem Inf Model (2013) 1.09

Molecular switch controlling the binding of anionic bile acid conjugates to human apical sodium-dependent bile acid transporter. J Med Chem (2010) 1.07

Desmethyl Macrolide Analogues to Address Antibiotic Resistance: Total Synthesis and Biological Evaluation of 4,8,10-Tridesmethyl Telithromycin. ACS Med Chem Lett (2011) 1.03

Adaptation of iron homeostasis pathways by a Pseudomonas aeruginosa pyoverdine mutant in the cystic fibrosis lung. J Bacteriol (2014) 1.02

Computational ligand-based rational design: Role of conformational sampling and force fields in model development. Medchemcomm (2011) 1.01

CHARMM additive and polarizable force fields for biophysics and computer-aided drug design. Biochim Biophys Acta (2014) 1.01

Binding response: a descriptor for selecting ligand binding site on protein surfaces. J Chem Inf Model (2007) 0.97

Turning defense into offense: defensin mimetics as novel antibiotics targeting lipid II. PLoS Pathog (2013) 0.97

Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach. Curr Comput Aided Drug Des (2011) 0.97

3D database searching in drug design. J Med Chem (1992) 0.97

Balancing target flexibility and target denaturation in computational fragment-based inhibitor discovery. J Comput Chem (2012) 0.96

Towards a new age of virtual ADME/TOX and multidimensional drug discovery. J Comput Aided Mol Des (2002) 0.93

Iron Depletion Enhances Production of Antimicrobials by Pseudomonas aeruginosa. J Bacteriol (2015) 0.91

Computer-aided drug design: the next 20 years. J Comput Aided Mol Des (2007) 0.90

Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities. ACS Chem Neurosci (2013) 0.90

Site-Identification by Ligand Competitive Saturation (SILCS) assisted pharmacophore modeling. J Comput Aided Mol Des (2014) 0.89

Inhibition of the bacterial heme oxygenases from Pseudomonas aeruginosa and Neisseria meningitidis: novel antimicrobial targets. J Med Chem (2007) 0.89

Design and evaluation of a molecular fingerprint involving the transformation of property descriptor values into a binary classification scheme. J Chem Inf Comput Sci (2003) 0.89

The P. aeruginosa heme binding protein PhuS is a heme oxygenase titratable regulator of heme uptake. ACS Chem Biol (2013) 0.88

Impact of ribosomal modification on the binding of the antibiotic telithromycin using a combined grand canonical monte carlo/molecular dynamics simulation approach. PLoS Comput Biol (2013) 0.88

Sampling of Organic Solutes in Aqueous and Heterogeneous Environments Using Oscillating Excess Chemical Potentials in Grand Canonical-like Monte Carlo-Molecular Dynamics Simulations. J Chem Theory Comput (2014) 0.88

Site-Specific Fragment Identification Guided by Single-Step Free Energy Perturbation Calculations. J Chem Theory Comput (2012) 0.88

Lead validation and SAR development via chemical similarity searching; application to compounds targeting the pY+3 site of the SH2 domain of p56lck. J Chem Inf Model (2005) 0.87

Mapping functional group free energy patterns at protein occluded sites: nuclear receptors and G-protein coupled receptors. J Chem Inf Model (2015) 0.86

Pharmacophore modeling using site-identification by ligand competitive saturation (SILCS) with multiple probe molecules. J Chem Inf Model (2015) 0.83

Consensus 3D model of μ-opioid receptor ligand efficacy based on a quantitative Conformationally Sampled Pharmacophore. J Phys Chem B (2011) 0.83

Small molecule antivirulents targeting the iron-regulated heme oxygenase (HemO) of P. aeruginosa. J Med Chem (2013) 0.82

Molecular mechanics. Curr Pharm Des (2014) 0.81

Enhanced conformational sampling using replica exchange with concurrent solute scaling and hamiltonian biasing realized in one dimension. J Chem Theory Comput (2015) 0.81

Conformational sampling of oligosaccharides using Hamiltonian replica exchange with two-dimensional dihedral biasing potentials and the weighted histogram analysis method (WHAM). J Chem Theory Comput (2015) 0.80

Automated selection of compounds with physicochemical properties to maximize bioavailability and druglikeness. J Chem Inf Model (2010) 0.79

Desmethyl Macrolides: Synthesis and Evaluation of 4,8,10-Tridesmethyl Cethromycin. ACS Med Chem Lett (2013) 0.78

Interplay of the bacterial ribosomal A-site, S12 protein mutations and paromomycin binding: a molecular dynamics study. PLoS One (2014) 0.78

Site Identification by Ligand Competitive Saturation (SILCS) simulations for fragment-based drug design. Methods Mol Biol (2015) 0.78

Identification of potential targets in Staphylococcus aureus N315 using computer aided protein data analysis. Bioinformation (2013) 0.78

Structure-activity exploration of a small-molecule Lipid II inhibitor. Drug Des Devel Ther (2015) 0.77

Desmethyl macrolides: synthesis and evaluation of 4-desmethyl telithromycin. ACS Med Chem Lett (2014) 0.76

Computational analysis of structure-activity relationships. Prog Med Chem (2010) 0.75